Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher R. Cline currently holds 118,658 shares of Travere Therapeutics, Inc. (TVTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher R. Cline has been a net seller of TVTX stock. They have purchased $0 and sold $1.2M worth of shares.
Christopher R. Cline's most recent insider trade was on May 6, 2026, when they sold 310 shares at $43.95 per share.
Christopher R. Cline serves as Executive at Travere Therapeutics, Inc. (TVTX). They have executed 28 insider transactions totaling $1.2M over their tenure at the company.
Christopher R. Cline holds the position of Executive at Travere Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Christopher R. Cline has shown a selling trading pattern, with $0 in total purchases and $1.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Christopher R. Cline was on Dec 1, 2025, when they sold $700.2K worth of TVTX shares. This transaction involved 20,000 shares at $35.01 per share.
Christopher R. Cline currently owns 118,658 shares of Travere Therapeutics, Inc. (TVTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher R. Cline's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher R. Cline has 28 Form 4 filings on record as an insider at Travere Therapeutics, Inc..
Set alerts for Christopher R. Cline and 40,000+ other insiders.